A Study of A-101 Topical Solution Administered Twice a Week in Subjects With Common Warts
Clinical trial NCT03278028 · COMPLETED
Trial details
- NCT number
- NCT03278028
- Sponsor
- Aclaris Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-13
- Primary completion
- 2018-03-01
- Enrollment
- 159
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.